CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $288,539
- in 2 filings, $289K under 10b5-1 plans
Net −$288,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-11 | WILLIAMS KRISTEN Chief Administrative Officer | Grant or award | +54,546 | 185,849 | ||
| 2026-02-11 | Teehan Brendan Chief Commercial Officer | Grant or award | +51,714 | 100,934.27 | ||
| 2026-02-11 | RIKER LAUREN Senior Vice President, Finance | Grant or award | +19,273 | 71,586.24 | ||
| 2026-02-11 | SLONIN JONATHAN Chief Medical Officer | Grant or award | +54,546 | 226,901.18 | ||
| 2026-02-11 | Lee Frank D. Chief Executive Officer | Grant or award | +261,818 | 660,830.84 | ||
| 2026-02-02 | RIKER LAUREN Senior Vice President, Finance | Sale 10b5-1 | −4,000 | $20.81 | $83K | 52,313.24 |
| 2026-02-02 | WILLIAMS KRISTEN Chief Administrative Officer | Sale 10b5-1 | −13,137 | $20.53 | $270K | 131,303 |
| 2026-01-30 | RIKER LAUREN Senior Vice President, Finance | Shares withheld for taxes 10b5-1 | −2,751 | $20.54 | $57K | 56,313.24 |
| 2026-01-30 | WILLIAMS KRISTEN Chief Administrative Officer | Shares withheld for taxes 10b5-1 | −17,134 | $20.54 | $352K | 144,440 |
| 2026-01-30 | SLONIN JONATHAN Chief Medical Officer | Shares withheld for taxes | −6,168 | $20.54 | $127K | 172,355.18 |
| 2026-01-30 | Teehan Brendan Chief Commercial Officer | Shares withheld for taxes | −5,182 | $20.54 | $106K | 49,220.27 |
| 2026-01-30 | Lee Frank D. Chief Executive Officer | Shares withheld for taxes | −41,488 | $20.54 | $852K | 399,012.84 |
| 2026-01-27 | Hirawat Samit Director | Grant or award · Stock Option (Right to Buy) | +39,291 | 39,291 | ||
| 2026-01-05 | RIKER LAUREN Senior Vice President, Finance | Sale 10b5-1 | −1,416 | $24.24 | $34K | 59,064.24 |
| 2026-01-02 | SLONIN JONATHAN Chief Medical Officer | Shares withheld for taxes | −381 | $24.46 | $9K | 178,523.18 |
| 2026-01-02 | RIKER LAUREN Senior Vice President, Finance | Shares withheld for taxes 10b5-1 | −159 | $24.46 | $4K | 60,480.24 |
| 2026-01-02 | Lee Frank D. Chief Executive Officer | Shares withheld for taxes | −9,272 | $24.46 | $227K | 440,500.84 |
| 2025-12-31 | Teehan Brendan Chief Commercial Officer | Grant or award | +402.27 | $10.76 | $4K | 54,402.27 |
| 2025-12-10 | Cross Shawn Chief Financial Officer | Option exercise 10b5-1 | +9,104 | $16.45 | $150K | 65,354 |
| 2025-12-10 | Cross Shawn Chief Financial Officer | Sale 10b5-1 | −9,104 | $25.14 | $229K | 56,250 |
Page 3 of 9 · 161 trades